Sign in

CIK 0001628171

  • Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472029180
Phone
+1 650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
  1. 4 Planned sale Director sold 2,155 shares at $37.00 ($79,735)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Planned sale General Counsel sold 1,500 shares at an average $30.99 ($46,481)
  4. 4 Planned sale General Counsel sold 1,252 shares at $31.58 ($39,542)
  5. 4 Planned sale Kelsey Stephen Michael sold 2,123 shares at $31.58 ($67,051)
  6. 4 Planned sale Chief Operating Officer sold 2,914 shares at $31.58 ($92,033)
  7. 4 Planned sale GOLDSMITH MARK A sold 5,788 shares at $31.58 ($182,804)
  8. 4 Planned sale Chief Financial Officer sold 1,261 shares at $31.58 ($39,826)
  9. 4 Planned sale Chief Operating Officer sold 23,671 shares at an average $34.04 ($805,652)
  10. 4 Grant or award Chief Operating Officer acquired 41,000 shares (grant or award)
  11. 4 Grant or award GOLDSMITH MARK A acquired 90,000 shares (grant or award)
  12. 4 Grant or award General Counsel acquired 21,000 shares (grant or award)
  13. 4 Grant or award Kelsey Stephen Michael acquired 51,400 shares (grant or award)
  14. 4 Grant or award Chief Financial Officer acquired 26,400 shares (grant or award)
  15. 4 Grant or award Wang Xiaolin acquired 24,200 shares (grant or award)
  16. 4 Planned sale General Counsel sold 1,500 shares at $27.00 ($40,500)
  17. 4 Planned sale Kelsey Stephen Michael sold 3,337 shares at $29.01 ($96,809)
  18. 4 Planned sale Kelsey Stephen Michael sold 13,330 shares at $29.10 ($387,884)
  19. 4 Planned sale Kelsey Stephen Michael sold 33,334 shares at $29.01 ($966,996)
  20. 4 Planned sale Chief Financial Officer sold 1,775 shares at $25.90 ($45,976)

Page 10 of 21 · 414 filings